Veterinary Medicines

Avishield ND B1 + IB H120

Authorised
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain B1 Hitchner, Live
Download as PDF

Product identification

Medicine name:
Avishield ND B1 + IB H120
Active substance:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
  • Newcastle disease virus, strain B1 Hitchner, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use
  • In drinking water use

Product details

Active substance and strength:
  • Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
    4.50
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Newcastle disease virus, strain B1 Hitchner, Live
    7.00
    log10 50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 1000 dose.
  • The vaccine is filled into colourless glass vials (type I), which are closed with rubber stoppers (brombutyl) and sealed with aluminium caps. 2500 dose.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Genera d.d.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera Research Ltd.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 3964/x/18 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Hungary
Procedure number:
  • HU/V/0129/001
Concerned member states:
  • Croatia
  • Slovenia